Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04271358 · ClinicalTrials.gov registry record · NA
Peer Coaching Intervention in Young Adults With Congenital Heart Disease
A NA study of Congenital Heart Disease and Congenital Heart Defect, sponsored by Duke University.
- Active
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04271358: Active NA study of Congenital Heart Disease and Congenital Heart Defect, sponsored by Duke University.
NCT04271358 is a NA study of Congenital Heart Disease and Congenital Heart Defect that is active but no longer recruiting, run by Duke University. The registered enrollment target is 33 participants, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04271358, a NA study of Congenital Heart Disease and Congenital Heart Defect, is active but no longer recruiting, sponsored by Duke University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate a peer coaching intervention in young adults with congenital heart disease.
Primary Outcome
Evaluate the number of participants contacted about the study who actually enrolled
Conditions Studied
Interventions
- BEHAVIORAL Peer Health Coaching
Study Locations (1)
North Carolina
- Duke Health - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2020-10-08 |
| Est. Completion | 2032-03-02 |
| Phase | NA |
What the registry record for NCT04271358 still lists
NCT04271358 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 473-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Peer Health Coaching is the first listed.
NCT04271358 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04271358 about?
NCT04271358 is a clinical study titled "Peer Coaching Intervention in Young Adults With Congenital Heart Disease". The purpose of the study is to evaluate a peer coaching intervention in young adults with congenital heart disease.
What is the current status of trial NCT04271358?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 33 participants. The study started on 2020-10-08. Estimated completion is 2032-03-02.
What conditions does trial NCT04271358 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Congenital Heart Defect.
What interventions are being tested in trial NCT04271358?
The interventions under investigation include: Peer Health Coaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT04271358?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04271358 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04271358's enrollment target sits among peer trials
33 55th of 63 higher than 9 of 63 other Congenital Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Congenital Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fontan Fitness Trial
RECRUITING · NA
-
Blood Conservation in Patients (3.5-12kg) Undergoing Congenital Cardiac Surgery
RECRUITING · NA
-
The Sequencing for Detection in Congenital Heart Disease (SD-CHD) Study
RECRUITING · NA
-
Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study
RECRUITING · NA
-
A Study of Hemodynamic Cardiopulmonary Exercise for CHD
RECRUITING · NA
-
Ventripoint Single Ventricle Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI